Tags

Type your tag names separated by a space and hit enter

Screening and diagnostic testing protocols for HIV and Syphilis infections in health care setting in Qatar: Evaluation and recommendations.
PLoS One. 2023; 18(2):e0278079.Plos

Abstract

BACKGROUND

HIV and Syphilis are common STIs, which have become a concern and burden on healthcare systems, as many infections go untreated and lead to potentially serious complications. HIV is usually diagnosed with Western blot, PCR, and p24 antigen testing. Whereas, Syphilis is mainly diagnosed through clinical findings and serologic testing. The Medical Commission Department (MC) under MOPH is responsible for screening all newcomers to Qatar, aiming to keep the country free from serious infectious diseases.

OBJECTIVE

We aimed to evaluate the diagnostic efficiency of the protocols used in the MC for screening HIV and Syphilis infections.

METHODS

We conducted a retrospective study of samples analyzed by 4th Generation ARCHITECT® HIV Ag/Ab Combo and Rapid Plasma Reagin (RPR) between January to December 2019. ARCHITECT® HIV Ag/Ab Combo positive samples were confirmed by INNO-LIA™ HIVI/II and RT-PCR. RPR-reactive samples were confirmed by ARCHITECT® Syphilis Treponema pallidium Antibody (Syphilis TPA) assay.

RESULTS

For HIV, data were collected from 585,587 individuals, of which 595 (0.1%) were positive by the ARCHITECT® HIV Ag/Ab Combo (Analyzer A). When all initially positive sera were re-tested on newly collected blood samples using different ARCHITECT® HIV Ag/Ab Combo analyzer (analyzer B), 99.8% (594/595) of samples were also positive, suggesting high reproducibility. The positive predictive value (PPV) between ARCHITECT® HIV Ag/Ab Combo and the INNO-LIA™ HIVI/II confirmatory assay was 31.8%. The PPV between ARCHITECT® HIV Ag/Ab Combo and HIV-PCR assay was 26.8%. Retrospective data for Syphilis were collected from a total of 97,298 individuals who visited the MC, of which 198 (0.20%) were initially positive by RPR. The PPV between RPR and Syphilis TPA confirmatory assay was 36.6%.

CONCLUSION

Despite the high rate of false positivity using ARCHITECT® HIV Ag/Ab Combo and RPR screening assays, both assays have proven to be highly effective as screening testing methods.

Authors+Show Affiliations

Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar. Biomedical Research Center, Qatar University, Doha, Qatar.Medical Commission Department, Laboratory Section, Ministry of Public Health, Doha, Qatar.Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar. Biomedical Research Center, Qatar University, Doha, Qatar.Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar. World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.Biomedical Research Center, Qatar University, Doha, Qatar. College of Medicine, QU Health, Qatar University, Doha, Qatar.Medical Commission Department, Laboratory Section, Ministry of Public Health, Doha, Qatar.Medical Commission Department, Laboratory Section, Ministry of Public Health, Doha, Qatar.Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar. Biomedical Research Center, Qatar University, Doha, Qatar.Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar. World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.College of Medicine, QU Health, Qatar University, Doha, Qatar.Medical Commission Department, Laboratory Section, Ministry of Public Health, Doha, Qatar.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

36749795

Citation

Nasrallah, Gheyath K., et al. "Screening and Diagnostic Testing Protocols for HIV and Syphilis Infections in Health Care Setting in Qatar: Evaluation and Recommendations." PloS One, vol. 18, no. 2, 2023, pp. e0278079.
Nasrallah GK, Al-Buainain R, Younes N, et al. Screening and diagnostic testing protocols for HIV and Syphilis infections in health care setting in Qatar: Evaluation and recommendations. PLoS One. 2023;18(2):e0278079.
Nasrallah, G. K., Al-Buainain, R., Younes, N., Dargham, S. R., Al-Sadeq, D. W., Elhassan, M., Al-Shaar, I., Yassine, H. M., Abu-Raddad, L. J., Emara, M. M., & Ismail, A. (2023). Screening and diagnostic testing protocols for HIV and Syphilis infections in health care setting in Qatar: Evaluation and recommendations. PloS One, 18(2), e0278079. https://doi.org/10.1371/journal.pone.0278079
Nasrallah GK, et al. Screening and Diagnostic Testing Protocols for HIV and Syphilis Infections in Health Care Setting in Qatar: Evaluation and Recommendations. PLoS One. 2023;18(2):e0278079. PubMed PMID: 36749795.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Screening and diagnostic testing protocols for HIV and Syphilis infections in health care setting in Qatar: Evaluation and recommendations. AU - Nasrallah,Gheyath K, AU - Al-Buainain,Raniya, AU - Younes,Nadin, AU - Dargham,Soha R, AU - Al-Sadeq,Duaa W, AU - Elhassan,Mohamed, AU - Al-Shaar,Ibrahim, AU - Yassine,Hadi M, AU - Abu-Raddad,Laith J, AU - Emara,Mohamed M, AU - Ismail,Ahmed, Y1 - 2023/02/07/ PY - 2022/11/07/received PY - 2022/12/22/accepted PY - 2023/2/7/entrez PY - 2023/2/8/pubmed PY - 2023/2/10/medline SP - e0278079 EP - e0278079 JF - PloS one JO - PLoS One VL - 18 IS - 2 N2 - BACKGROUND: HIV and Syphilis are common STIs, which have become a concern and burden on healthcare systems, as many infections go untreated and lead to potentially serious complications. HIV is usually diagnosed with Western blot, PCR, and p24 antigen testing. Whereas, Syphilis is mainly diagnosed through clinical findings and serologic testing. The Medical Commission Department (MC) under MOPH is responsible for screening all newcomers to Qatar, aiming to keep the country free from serious infectious diseases. OBJECTIVE: We aimed to evaluate the diagnostic efficiency of the protocols used in the MC for screening HIV and Syphilis infections. METHODS: We conducted a retrospective study of samples analyzed by 4th Generation ARCHITECT® HIV Ag/Ab Combo and Rapid Plasma Reagin (RPR) between January to December 2019. ARCHITECT® HIV Ag/Ab Combo positive samples were confirmed by INNO-LIA™ HIVI/II and RT-PCR. RPR-reactive samples were confirmed by ARCHITECT® Syphilis Treponema pallidium Antibody (Syphilis TPA) assay. RESULTS: For HIV, data were collected from 585,587 individuals, of which 595 (0.1%) were positive by the ARCHITECT® HIV Ag/Ab Combo (Analyzer A). When all initially positive sera were re-tested on newly collected blood samples using different ARCHITECT® HIV Ag/Ab Combo analyzer (analyzer B), 99.8% (594/595) of samples were also positive, suggesting high reproducibility. The positive predictive value (PPV) between ARCHITECT® HIV Ag/Ab Combo and the INNO-LIA™ HIVI/II confirmatory assay was 31.8%. The PPV between ARCHITECT® HIV Ag/Ab Combo and HIV-PCR assay was 26.8%. Retrospective data for Syphilis were collected from a total of 97,298 individuals who visited the MC, of which 198 (0.20%) were initially positive by RPR. The PPV between RPR and Syphilis TPA confirmatory assay was 36.6%. CONCLUSION: Despite the high rate of false positivity using ARCHITECT® HIV Ag/Ab Combo and RPR screening assays, both assays have proven to be highly effective as screening testing methods. SN - 1932-6203 UR - https://www.unboundmedicine.com/medline/citation/36749795/Screening_and_diagnostic_testing_protocols_for_HIV_and_Syphilis_infections_in_health_care_setting_in_Qatar:_Evaluation_and_recommendations. DB - PRIME DP - Unbound Medicine ER -